Lilly plans to enroll up to 140 participants with the study expected to be completed next year. Liver disease Novo's Wegovy ...

BANGKOK – Shares were mixed in Asia on Tuesday after Wall Street held near its records, with traders awaiting fresh cues ...

Trump’s possible next move, Winklevoss twins jump into hot IPO market, Palo Alto Networks issues rosy guidance, and more news to start your day.

An outbreak of Legionnaires’ disease in City’s Harlem neighborhood thought to have originated in contaminated cooling towers ...

This episode of Pharma Pulse covers Novo Nordisk’s FDA win for Wegovy in MASH-related liver fibrosis, new research on a ...

U.S. stocks closed a listless day nearly flat as investors wait for key retail earnings and an annual Fed conference for ...